Article Information
History
- November 2, 2022.
Article Versions
- You are currently viewing Version 1 of this article (November 2, 2022 - 13:26).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chaitanya Kurhade1,#,
- Jing Zou1,#,
- Hongjie Xia1,
- Mingru Liu2,
- Hope C. Chang2,
- Ping Ren2,*,
- Xuping Xie1,* and
- Pei-Yong Shi1,3,4,5,6,*
- 1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA
- 2Department of Pathology, University of Texas Medical Branch, Galveston Texas, USA
- 3Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USA
- 4Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA
- 5Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA
- 6Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA
- ↵*Corresponding authors: P.R. (peren{at}utmb.edu), X.X. (xuxie{at}utmb.edu), or P.-Y.S. (peshi{at}utmb.edu)
↵# C.K. and J.Z. made equal contributions to the study.
Posted November 02, 2022.
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster
